C.R. Sincock

C.R. Sincock is a prominent business executive with extensive experience in the aviation and biotechnology industries. Here's an overview of his career and accomplishments:

Professional Experience

C.R. Sincock currently holds several key positions:

• Chief Executive Officer (CEO) at Avflight Corporation, a role he has held since 20171
• Executive Vice President at Avfuel Corporation, a position he assumed in 20191
• Founding Investor and Senior Strategic Advisor at Kriya Therapeutics2

Career Progression

Sincock's career journey has been diverse and impressive:

• Started as a Summer Intern at Acuity Brands in 20061
• Worked as an Investment Analyst at QVT Financial LP in 200712
• Held various roles at Avfuel Corporation from 2008 to 2018, including Managing Director of Business Development and Director of International Business Development1
• Founded Transhuman Capital in 2014 and serves as the Managing Partner12
• Co-founded Dvant Pharma in 2021 and serves as the Executive Chairman1

Board Memberships

Sincock is actively involved in several organizations:

• Board Member at Kriya Therapeutics (since 2019)1
• Board Member at the National Air Transportation Association (since 2021)1
• Investment Advisory Board Member at the University of Michigan Biomedical Venture Fund (since 2021)12

Education

Sincock has a strong educational background:

• Bachelor of Arts in Economics from Harvard University (2003-2007)1
• Master of Business Administration (MBA) from Harvard Business School (2011-2013), where he was a Baker Scholar12
• Currently pursuing a Master of Science (M.S.) in Biotechnology at The Johns Hopkins University (expected completion in 2025)12

Entrepreneurship and Investments

Sincock has demonstrated a keen interest in entrepreneurship and investing:

• Founder and managing partner of Transhuman Capital, a family office venture capital fund focusing on early-stage biotechnology companies2
• Made significant investments in companies like Roivant Sciences and Kriya Therapeutics2
• Founding investor in Dvant Pharma, a small molecule oncology company2

C.R. Sincock's diverse experience spans aviation, biotechnology, and finance, making him a multifaceted executive with a strong track record in business development and investment.